Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03430271 · ClinicalTrials.gov registry record · NA
Enhancing Independence Using Group-based Community Interventions for Healthy AGing in Elders: the ENGAGE Pilot Study
A NA study of Mobility Limitation, sponsored by Tufts University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 2
- Study locations
NCT03430271: Completed NA study of Mobility Limitation, sponsored by Tufts University.
NCT03430271 is a NA study of Mobility Limitation that has completed, run by Tufts University. The registered enrollment target is 59 participants, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03430271, a NA study of Mobility Limitation, has completed, sponsored by Tufts University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will be conducted to determine the safety and feasibility of translating a physical activity intervention (LIFE Study) into a community setting. Study outcomes include physical performance, safety, and feasibility of conducting the LIFE PA intervention in a community setting.
Primary Outcome
Safety will be measured by the number of adverse events and serious adverse events. The investigators will compare the rates of adverse events and serious adverse events between the physical activity and healthy aging education intervention randomized arms.
Conditions Studied
Interventions
- OTHER Physical Activity Intervention
- OTHER Healthy Aging Intervention
Study Locations (2)
Massachusetts
- Jean Mayer Human Nutrition Research Center on Aging at Tufts University - Boston
- Somerville Council on Aging Holland Street Senior Center - Somerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-05-12 |
| Est. Completion | 2016-06-30 |
| Phase | NA |
What the finished NCT03430271 record still lists
NCT03430271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity Intervention is the first listed.
NCT03430271 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03430271 about?
NCT03430271 is a clinical study titled "Enhancing Independence Using Group-based Community Interventions for Healthy AGing in Elders: the ENGAGE Pilot Study". This study will be conducted to determine the safety and feasibility of translating a physical activity intervention (LIFE Study) into a community setting. Study outcomes include physical performance, safety, and feasibility of conducting the LIFE PA intervention in a community setting.
What is the current status of trial NCT03430271?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-05-12. Estimated completion is 2016-06-30.
What conditions does trial NCT03430271 study?
This clinical trial studies the following conditions: Mobility Limitation.
What interventions are being tested in trial NCT03430271?
The interventions under investigation include: Physical Activity Intervention (OTHER), Healthy Aging Intervention (OTHER).
Who is sponsoring clinical trial NCT03430271?
This trial is sponsored by Tufts University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03430271 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mobility Limitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03430271's enrollment target sits among peer trials
59 16th of 28 higher than 13 of 28 other Mobility Limitation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mobility Limitation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients
RECRUITING · NA
-
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
ACTIVE NOT RECRUITING · NA
-
Telehealth Based Intervention to Improve Functional Capacity in Survivors of Childhood Cancer With Significantly Limited Exercise Tolerance
ACTIVE NOT RECRUITING · NA
-
Randomized Clinical Trial to Improve Mobility After Hospitalization
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI